Medicines, 2022
Shortlist up to four to read them side by side.
1,349 medicine recalls FDA’s Enforcement Report published in 2022, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 6, 2026.
1,349of 1,349 medicine recallsshown with your filters
The list
- Medicine recall Ultratest Testosterone Cypionate 160 mg/mL Testosterone Propionate 40 mg/mL, Multi-Dose 10 mL vial Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Vitamin D3 (50,000 IU/mL)Multi-Dose 30 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155… Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Zinc Chloride Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Alpha Lipoic Acid 25 mg/mL, Multi-Dose 30 mL vial Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Preserved Ascorbic Acid 500 mg/mL, Multi-Dose 30 mL vial Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall AT-6 Papaverine 40 mg/mL Phentolamine 4 mg/mL Atropine 0.3 mg/mL, Multi-Dose 10 mL vial Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Bimix-3 Papaverine 30 mg/mL Phentolamine 3 mg/mL Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Calcium Chloride 10% Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Cyanocobalamin 2 mg/mL, Multi-Dose 10 mL vial Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Pyridoxine 100 mg/mL, Multi-Dose 30 mL vial Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Dexpanthenol 250 mg/mL Multi-Dose 30 mL Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall FA Papaverine 20 mg/mL Phentolamine 2 mg/mL Alprostadil 20 mcg/mL Atropine 0.2 mg/mL, Multi-Dose 10 mL vial Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Folic Acid 1 mg/mL Hydroxocobalamin 1 mg/mL, Multi-Dose 30 mL vial Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Formula F1 Papaverine 1.8 mg/mL Phentolamine 0.2 mg/mL Alprostadil 18 mcg/mL Atropine 0.02 mg/mL Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Formula F2 Papaverine 9 mg/mL Phentolamine 1 mg/mL Alprostadil 10 mcg/mL Atropine 0.1 mg/mL, Multi-Dose 10 mL… Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Formula F9 Papaverine 0.9 mg/mL Phentolamine 0.1 mg/mL PGE 20 mcg/mL Atropine 0.01 mg/mL, Multi-Dose 10 mL… Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Lidocaine 2% Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Lidocaine 1%/Epinephrine 1:100,000/mL, Multi-Dose 30 mL vial Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Lipo-Mino-Mix Pyridoxine HCL (B6) 2 mg/mL Methionine 12.4 mg/mL Inositol 25 mg/mL Choline Chloride 25 mg/mL… Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Lipostat-Plus Methionine 25 mg/mL Inositol 50 mg/mL Choline Chloride 50 mg/mL Cyanocobalamin 1 mg/mL… Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Lipostat Plus SF Inositol 50 mg/mL Choline Chloride 50 mg/mL Cyanocobalamin 1 mg/mL Pyridoxine HCL 175 mcg/mL… Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Magnesium Chloride, 200 mg/mL, Multi-Dose 30 mL vial Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Methylcobalamin 5 mg/mL Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall MICC, Methionine 25 mg/mL Inositol 50 mg/mL Choline Chloride 50 mg/mL Cyanobalamin 330 mcg/mL Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Myers Cocktail, Magnesium Chloride 9.65 mg/mL Dexpanthenol 4.07 mg/mL Thiamine HCL 1.62 mg/mL… Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall NB-343 Papaverine 30 mg/mL Phentolamine 3 mg/mL PGE 30 mcg/mL, Multi-Dose 10 mL vial Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Olympia Mineral Blend Magnesium Chloride 80 mg/mL Zinc Sulfate 1 mg/mL Manganese Sulfate 20 mcg/mL Copper… Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Olympia Vita-Complex Thiamine HCL (B1) 100 mg/mL Niacinamide (B3) 100 mg/mL Riboflavin 5 P04 (B2) 2 mg/mL… Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Ondansetron Hydrochloride, 1 mg/mL, Multi-Dose 30 mL vial Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall PGE-3 Alprostadil 150 mcg/mL, Multi-Dose 10 mL vial Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Phenylephrine 1 mg/mL, Multi-Dose 5 mL vial Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Pyridoxine HCL 100 mg/mL, Multi-Dose 30 mL vial Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall QM-2 Papaverine 30 mg/mL Phentolamine 3 mg/mL Alprostadil 60 mcg/mL Atropine 0.2 mg/mL Multi-Dose 10 mL Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall QM-3 Papaverine 30 mg/mL Phentolamine 3 mg/mL Alprostadil 150 mcg/mL Atropine 0.2 mg/mL, Multi-Dose 10 mL vial Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Amino Blend Glutamine 30 mg/mL Ornithine HCL 50 mg/mL Arginine HCL 100 mg/mL Lysine HCL 50 mg/mL Citrulline… Lack of assurance of sterility. Class IIFDA’s classJun 1, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedJun 1, 2022ClassClass IIStatusCompletedWhereNationwide, and Puerto Rico and US Virgin Islands named
- Medicine recall Benzphetamine tablets, 50mg, CIII, repackaged Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets… Class IIIFDA’s classJun 1, 2022in FDA’s Enforcement ReportGeorgiathe one state its words name PublishedJun 1, 2022ClassClass IIIStatusTerminatedWhereGeorgia
- Medicine recall Benzonatate capsules, 100mg, repackaged Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets… FDA Class I, its most serious class Class IFDA’s class (needs attention)Jun 1, 2022in FDA’s Enforcement ReportGeorgiathe one state its words name PublishedJun 1, 2022ClassClass IStatusTerminatedWhereGeorgia
- Medicine recall MILK OF MAGNESIA USP, (Magnesium Hydroxide), 2400 mg/30 mL, 30 mL cup Microbial Contamination of Non-Sterile Products FDA Class I, its most serious class Class IFDA’s class (needs attention)May 25, 2022in FDA’s Enforcement ReportIndianathe one state its words name PublishedMay 25, 2022ClassClass IStatusCompletedWhereIndiana
- Medicine recall Magnesium Hydroxide 1200mg, Aluminum Hydroxide 1200mg, Simethicone 120mg, 30 mL cup Microbial Contamination of Non-Sterile Products FDA Class I, its most serious class Class IFDA’s class (needs attention)May 25, 2022in FDA’s Enforcement ReportIndianathe one state its words name PublishedMay 25, 2022ClassClass IStatusCompletedWhereIndiana
- Medicine recall Acetaminophen Oral Solution, USP 650mg/ 20.3 mL cup CGMP Deviations: Failure to properly investigate failed microbial testing. Class IIFDA’s classMay 25, 2022in FDA’s Enforcement ReportIndianathe one state its words name PublishedMay 25, 2022ClassClass IIStatusCompletedWhereIndiana
- Medicine recall MILK OF MAGNESIA USP, (Magnesium Hydroxide), 2400 mg/30 mL, 30 mL cup CGMP Deviations: Failure to properly investigate failed microbial testing. Class IIFDA’s classMay 25, 2022in FDA’s Enforcement ReportIndianathe one state its words name PublishedMay 25, 2022ClassClass IIStatusCompletedWhereIndiana
- Medicine recall Magnesium Hydroxide 1200mg, Aluminum Hydroxide 1200mg, Simethicone 120mg, 30 mL cup CGMP Deviations: Failure to properly investigate failed microbial testing. Class IIFDA’s classMay 25, 2022in FDA’s Enforcement ReportIndianathe one state its words name PublishedMay 25, 2022ClassClass IIStatusCompletedWhereIndiana
- Medicine recall Accupril (Quinapril HCl Tablets) 10 mg, 90 Tablets CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits. Class IIFDA’s classMay 25, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMay 25, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Accupril (Quinapril HCl Tablets) 20 mg, 90 Tablets CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits. Class IIFDA’s classMay 25, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMay 25, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Accupril (Quinapril HCl Tablets) 40 mg, 90 Tablets CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits. Class IIFDA’s classMay 25, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMay 25, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall GaviLyte -C (Polyethylene Glycol 3350, 240 g) and electrolytes for Oral Solution, USP with flavor pack Failed Stability Specification Class IIFDA’s classMay 25, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMay 25, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Phenobarbital Elixir, USP 20 mg/5 mL, 1 Pint Does Not Meet USP or OTC Monograph: Product exceeds USP specification for alcohol content Class IIIFDA’s classMay 25, 2022in FDA’s Enforcement ReportTennesseethe one state its words name PublishedMay 25, 2022ClassClass IIIStatusTerminatedWhereTennessee
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.